Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00412919 · TERMINATED

Trial details

NCT number: NCT00412919
Sponsor: Bayside Health
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2006-12-01
Primary completion: 2008-11-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.